Lexicon Pharmaceuticals Inc (LXRX) — Capital Reinvestment Ratio
Latest as of September 2019:
0.00x
Lexicon Pharmaceuticals Inc (LXRX) has a Capital Reinvestment Ratio of 0.00x as of September 2019, meaning it reinvests 0% of its operating cash flow ($190.70 Million) in capital expenditures ($70.00K). See Lexicon Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$190.70 Million
USD
Capital Expenditures
$70.00K
USD
Data as of
Sep 2019
Most recent filing
Lexicon Pharmaceuticals Inc Capital Reinvestment Ratio (2005–2019)
This chart tracks Lexicon Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc from 2005 to 2019. For live market cap and broader valuation context, see market cap of Lexicon Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $113.81 Million | $70.00K | ▼ -87.5% |
| 2015 | 0.00x | $184.78 Million | $910.00K | ▼ -99.0% |
| 2005 | 0.48x | $23.44 Million | $11.28 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow